Ujjwala M Warawdekar1, Pradnya Kowtal2
1Scientific Officer ‘E’, ACTREC, Tata Memorial Centre, Navi Mumbai, Maharashtra, India
2Co-Investigator, Sarin Lab, ACTREC, Tata Memorial Centre, Navi Mumbai, Maharashtra, India
DOI: 10.4103/1477-3163.157434
ABSTRACT
The search for the most effective therapy with minimum side effects has always been the goal of oncologists and efforts to develop such therapies through understanding disease mechanisms has been the focus of many basic scientists in cancer research, leading to a common interest of convergence. The 5 th International Conference organized by the Carcinogenesis Foundation, USA and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, India, was held between February 11 th and 13 th 2015, at ACTREC. During these proceedings, the scientific community engaged in oncology research discussed novel ideas emerging from the laboratory and their translation into improved clinical outcomes. However, the lack of major success in the genesis of novel cancer therapeutics that is safe and provides long-term relief to patients is a challenge that needs to be overcome. The focus of this meeting was to highlight these challenges and to encourage collaborations between scientists and clinicians and clearly a message through exemplary scientific contribution was conveyed to all the dedicated scientists and clinician that even if two decades of tireless work on a single idea does not generate a reliable and safe therapy, the combat to rein cancer must not cease. In this report we have communicated some of the outstanding work done in the areas of cancer therapeutics, biomarkers and prevention and described the salient observations associated with cancer stem cells in disease progression and some of the pathways implicated in tumor progression.
Keywords: Carcinogenesis, conference report, cancer therapeutics
Keywords: Barrett′s esophagus, esophageal adenocarcinoma, single nucleotide polymorphisms